Effects of Modified Video-Implemented Script Training for Aphasia in the Three Variants of Primary Progressive Aphasia.


Journal

Journal of speech, language, and hearing research : JSLHR
ISSN: 1558-9102
Titre abrégé: J Speech Lang Hear Res
Pays: United States
ID NLM: 9705610

Informations de publication

Date de publication:
20 Sep 2024
Historique:
medline: 20 9 2024
pubmed: 20 9 2024
entrez: 20 9 2024
Statut: aheadofprint

Résumé

Primary progressive aphasia (PPA) is a neurodegenerative disorder characterized by worsening of speech and/or language. Script training intervention promotes automatized speech production via repeated practice of scripted content. This study evaluated the acceptability, feasibility, and effects of a modified version of Video-Implemented Script Training for Aphasia (VISTA) in the three PPA variants and compared outcomes by intervention modality (teletherapy vs. in person). Thirteen bilingual (Spanish-Catalan) participants were included (semantic variant, No significant differences were observed on the basis of intervention modality. Participants demonstrated significant improvements from pre- to post-intervention in script production, synonym production, keywords, and global quality on the trained script. Maintenance was observed when comparing performance at post-intervention relative to 3- and 6-month follow-up for script and synonym production. Significant improvement in production quality of the untrained topic was observed following intervention. Different patterns of benefit were observed by PPA variant. Modified VISTA was acceptable and effective across the three PPA variants, as evidenced by improvements on a broader array of outcome measures than those previously reported. Findings also provide further support for provision for teletherapy in individuals with PPA. https://doi.org/10.23641/asha.26999326.

Identifiants

pubmed: 39302879
doi: 10.1044/2024_JSLHR-23-00583
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-16

Auteurs

Núria Montagut (N)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.
Fundació Recerca Clínic Barcelona-Institut d'Investigació Biomèdica August Pi i Sunyer, Spain.
Faculty of Medicine, Institute of Neurosciences, University of Barcelona, Spain.

Sergi Borrego-Écija (S)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.
Fundació Recerca Clínic Barcelona-Institut d'Investigació Biomèdica August Pi i Sunyer, Spain.

Jorge Herrero (J)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.

Magdalena Castellví (M)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.

Mircea Balasa (M)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.
Fundació Recerca Clínic Barcelona-Institut d'Investigació Biomèdica August Pi i Sunyer, Spain.

Albert Lladó (A)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.
Fundació Recerca Clínic Barcelona-Institut d'Investigació Biomèdica August Pi i Sunyer, Spain.
Faculty of Medicine, Institute of Neurosciences, University of Barcelona, Spain.

Stephanie M Grasso (SM)

Department of Speech, Language, and Hearing Sciences, The University of Texas at Austin.

Raquel Sánchez-Valle (R)

Alzheimer's Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic Barcelona, Spain.
Fundació Recerca Clínic Barcelona-Institut d'Investigació Biomèdica August Pi i Sunyer, Spain.
Faculty of Medicine, Institute of Neurosciences, University of Barcelona, Spain.

Classifications MeSH